Updated for 2011 (full launch year actual) sales revenue -- Merck's Victrelis® (a supposed Ex-CEO Fred Hassan/legacy Schering-Plough "star") is getting trounced in the US marketplace by much-smaller Vertex's Incivek® -- and the trend will not reverse, despite Merck's use of third-party marketing muscle (Roche):
Ouch.
No comments:
Post a Comment